1,898 reports of this reaction
5.0% of all Wegovy reports
#2 most reported adverse reaction
VOMITING is the #2 most commonly reported adverse reaction for Wegovy, manufactured by Novo Nordisk. There are 1,898 FDA adverse event reports linking Wegovy to VOMITING. This represents approximately 5.0% of all 37,587 adverse event reports for this drug.
Patients taking Wegovy who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is moderately reported among Wegovy users, representing a notable but not dominant share of adverse events.
In addition to vomiting, the following adverse reactions have been reported for Wegovy:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 1,898 FDA reports for Wegovy. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 5.0% of all adverse event reports for Wegovy, making it one of the most commonly reported side effect.
If you experience vomiting while taking Wegovy, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.